Myc-oncogene inactivating effect by Proline Rich Polypeptide (PRP-1) in chondrosarcoma JJ012 cells

Neurochemical Research

Volumn 34, Issue 2, 2009, Pages 379-385

  Galoian, Karina ^a   Scully, Sean ^b   Galoyan, Armen ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI HOSPITAL   (United States)

^c H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

Author keywords

Cancer; Chondrosarcoma; Hypothalamic neuropeptides; Myc oncogene; Proline rich polypeptide

Indexed keywords

NEUROPEPTIDE; PROLINE RICH POLYPEPTIDE 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHONDROSARCOMA; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE INACTIVATION; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE MYC; PRIORITY JOURNAL; UPREGULATION;

CELL LINE, TUMOR; CHONDROSARCOMA; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, REPORTER; HUMANS; LUCIFERASES; PROLINE-RICH PROTEIN DOMAINS;

NUCLEOPOLYHEDROVIRUS;

EID: 58849100884     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9794-6     Document Type: Article

References (23)

1. Galoyan AA (2004) Brain neurosecretory cytokines: immune response and neuronal survival. Kluwer Academic/Plenum Publishers, NY
2. Galoyan AA (2008) The brain immune system: chemistry and biology of the signal molecules. In: Galoyan A, Besedovsky H (eds) Handbook of neurochemistry and molecular neurobiology, v.Neuroimmunology, Chap. 7, pp 155-195
3. AA Galoyan SL Grigorian ChV Badalyan 2006 Treatment and prophylaxis of anthrax by brain neurosecretory cytokines Neurochem Res 31 6 795 803
4. AA Galoyan JS Sarkissian VA Chavushyan 2005 Neuroprotective action of hypothalamic peptide PRP-1 at various time survival following spinal cord hemisection Neurochem Res 30 4 507 525
5. AA Galoyan 2000 Neurochemistry of brain neuroendocrine immune system: signal molecules Neurochem Res 25 9/10 1343 1355
6. AA Galoyan VS Aprikyan 2002 A new hypothalamic polypeptide is a regulator of myelopoiesis Neurochem Res 27 4 305 312
7. Galoyan AA, Shirvanian AJu (2006) Patent N 1696 A
8. GM Simonyan AK Nersesyan RM Simonyan MA Babayan MA Simonyan AA Galoyan 2005 Antitumor and antistressor effects of hypothalamic proline rich peptide (PRP-1) in sarcoma 45; possible biochemical mechanisms Neurochemistry (RAS and NAS RA) 22 2 125 130
9. AA Galoyan VA Shakhlamov LI Kondakova VI Altukhova GP Polyakova 2001 The influence of proline-rich polypeptide on the morphology and mitotic activity of neurinoma Hassel node of tumor cells at rats (electron microscopic investigations) PNAS (Russian Academy of Sciences) 101 2 279 286
10. 929 under PRP effect in vitro Med Sci Armenia 41 1 25 29
11. Mirra J (1989) In: Lea and Febiger, bone tumors. Philadelphia
12. FJ Frassica KK Unni JW Beabout FH Sim 1986 Dedifferentiated chondrosarcoma. A report of the clinicophathological features and treatment of seventy-eight cases J Bone Joint Surg Am 68 1197 1205
13. SP Scully KR Berend A Toth WN Qi Z Qi JA Block 2000 Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma Clin Orthop Relat Res 376 291 303
14. KA Galoian N Garamszegi SP Garamszegi SP Scully 2007 Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential Exp Biol Med 232 4 515 522
15. YC Fong WH Yang SF Hsu HC Hsu KF Tseng CJ Hsu CY Lee SP Scully 2007 Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells Orthop Res 25 8 1106 1114
16. BA Sherf 1996 Dual luciferase reporter assay: an advanced coreporter technology integrating firefly and renilla luciferase assays Promega Notes 57 2 9
17. AV Schally AM Cumaru-Schally A Nagy M Kovacs K Szepeshazi A Plonowski JL Varga Halmos 2001 Front Neuroendocrinol 22 248 291
18. CM Shachaf DW Felsher 2005 Tumor dormancy and Myc inactivation: pushing cancer to the brink of Normalcy Cancer Res 65 4471 4474
19. JM Bishop 1991 Molecular themes in oncogenesis Cell 64 235 48
20. BJ Druker CL Sawyers H Kantarjian 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 1038 1042
21. BJ Driker M Talpaz DJ Resta 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037
22. DW Felsher Nicole Bradon 2003 Pharmacological Inactivation of MYC for the treatment of cancer Drug News Perspect 16 6 370 374
23. DW Felsher 2003 Cancer revoked: oncogenes as therapeutic targets Nat Rev Cancer 3 375 8